PRELIMINARY FINDINGS FROM THE PHASE 2 EPPIK STUDY OF SPARSENTAN IN PEDIATRIC PATIENTS WITH SELECTED PROTEINURIC GLOMERULAR DISEASES
Back
14 Apr 2024
5:45 p.m.
6:45 p.m.
WCN24-AB-774, Poster Board= SUN-048
Radko Komers
Poster Presenter